JAZZ
Jazz Pharmaceuticals plc (Ireland) (JAZZ)
$
82About Jazz Pharmaceuticals plc (Ireland) (JAZZ)
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Details
Daily high
$138.27
Daily low
$134.76
Price at open
$137.65
52 Week High
$138.27
52 Week Low
$99.06
Market cap
8.2B
Dividend yield
0.00%
Volume
1.2M
Avg. volume
622,519
P/E ratio
19.51
Jazz Pharmaceuticals plc (Ireland) News
Details
Daily high
$138.27
Daily low
$134.76
Price at open
$137.65
52 Week High
$138.27
52 Week Low
$99.06
Market cap
8.2B
Dividend yield
0.00%
Volume
1.2M
Avg. volume
622,519
P/E ratio
19.51